This story was originally published July 5.
Genome British Columbia and the BC Cancer Foundation have formed a partnership to develop a genomic test to determine whether acute myeloid leukemia patients should receive chemotherapy or stem cell transplantation.
A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.
Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.
*Before your trial expires, we’ll put together a custom quote with your long-term premium options.
